Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
Scopus BioPharma Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
Scopus BioPharma Inc.Listing on record | Other | n/a (No price was disclosed in the filing) | SEC | ||
EyePoint, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EyePoint, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EyePoint, Inc.Listing on record | Buy | $8.4K | conv 86First in 12mo | SEC | |
EyePoint, Inc.Listing on record | Buy | $8.4K | conv 79First in 12mo | SEC | |
EyePoint, Inc.Listing on record | Buy | $8.1K | conv 79First in 12mo | SEC | |
EyePoint, Inc.Listing on record | Buy | $8.1K | conv 86First in 12mo | SEC | |
EyePoint, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EyePoint, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
EyePoint, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Fibrocell Science, Inc.Listing unverified | AwardD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
EyePoint, Inc.Listing on record | AwardD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
ADVANCED BIOTHERAPY INCListing unverified | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
ADVANCED BIOTHERAPY INCListing unverified | Other | n/a (No price was disclosed in the filing) | SEC |